Skip to main content
Equibles
ORKA logo

ORKA · Oruka Therapeutics, Inc.

Track ORKA — free

Use ORKA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ORKA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$91.15 -5.40 (-5.59%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$6.21B
Shares
66.21M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding ORKA

267 fund positions
Fund Balance Value % of Fund Open
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,555,002 $147,989,540 1.38%
SMALLCAP World Fund Inc 1,527,592 $145,380,931 0.15%
iShares Russell 2000 ETF 1,300,202 $123,740,224 0.15%
Fidelity Growth Company Fund 1,221,046 $71,467,822 0.07%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,374,750 $67,431,488 0.00%
Fidelity Advisor Biotechnology Fund 737,386 $50,444,576 2.65%
Select Health Care Portfolio 833,100 $48,761,343 0.84%
Fidelity Small Cap Growth Fund 685,718 $46,909,968 0.56%
T. Rowe Price Health Sciences Fund, Inc. 451,118 $42,932,900 0.36%
iShares Russell 2000 Growth ETF 449,195 $42,749,888 0.28%
T. Rowe Price Small-Cap Stock Fund, Inc. 381,128 $36,271,952 0.39%
iShares Biotechnology ETF 359,218 $34,186,777 0.38%
Select Biotechnology Portfolio 562,683 $32,933,836 0.63%
Fidelity Advisor Health Care Fund 424,000 $29,005,840 1.00%
Fidelity Small Cap Index Fund 381,549 $26,101,767 0.08%
abrdn Healthcare Investors 273,474 $26,026,521 1.91%
Putnam Small Cap Growth Fund 255,628 $24,328,117 0.72%
JPMorgan Small Cap Growth Fund 250,999 $23,887,575 0.92%
abrdn Healthcare Opportunities Fund 250,767 $23,865,495 2.89%
Fidelity Stock Selector Small Cap Fund 344,956 $23,598,440 0.34%
VANGUARD EXTENDED MARKET INDEX FUND 437,253 $21,447,260 0.03%
Janus Henderson Global Life Sciences Fund 222,082 $21,135,544 0.36%
Fidelity Growth Company K6 Fund 356,248 $20,851,195 0.08%
Fidelity Series Small Cap Opportunities Fund 301,472 $20,623,700 0.41%
Fidelity Small Cap Growth K6 Fund 295,854 $20,239,372 0.47%
T. Rowe Price Institutional Small-Cap Stock Fund 205,065 $19,516,036 0.39%
Fidelity Series Growth Company Fund 323,236 $18,919,003 0.08%
Nomura Healthcare Fund 190,000 $18,082,300 2.41%
Fidelity Contrafund 185,075 $17,613,588 0.01%
New Economy Fund 285,714 $16,722,840 0.03%
BlackRock Health Sciences Opportunities Portfolio 264,813 $15,499,505 0.26%
Franklin Biotechnology Discovery Fund 222,393 $15,213,905 1.47%
Fidelity Extended Market Index Fund 252,250 $14,764,193 0.03%
LORD ABBETT DEVELOPING GROWTH FUND INC 214,960 $14,705,414 0.66%
Franklin Small Cap Growth Fund 213,110 $14,578,855 0.60%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 150,800 $14,351,636 0.15%
VIP Health Care Portfolio 149,300 $14,208,881 1.23%
VANGUARD RUSSELL 2000 INDEX FUND 237,730 $13,914,337 0.08%
Schwab U.S. Small-Cap ETF 234,870 $13,746,941 0.06%
abrdn Life Sciences Investors 122,702 $11,677,549 1.69%
College Retirement Equities Fund - Total Global Stock Account 96,464 $9,180,479 0.01%
Fidelity Blue Chip Growth Fund 129,200 $8,838,572 0.01%
Master Small Cap Index Series 92,609 $8,813,599 0.15%
JPMorgan Small Cap Blend Fund 80,748 $7,684,787 0.45%
Harbor Small Cap Growth Fund 110,638 $7,568,746 0.29%
Fidelity U.S. Equity Central Fund 75,600 $7,194,852 0.03%
MFS New Discovery Value Fund 122,006 $7,141,011 0.29%
MFS New Discovery Fund 121,469 $7,109,581 0.33%
Bridge Builder Small/Mid Cap Value Fund 74,423 $7,082,837 0.07%
iShares Core S&P Total U.S. Stock Market ETF 67,743 $6,447,101 0.01%
Showing 1–50 of 267 positions
Key facts CIK 907654 CUSIP 687604108 13F (30d) 230 filings 225 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)